252 related articles for article (PubMed ID: 24446277)
1. Pharmacovigilance for children's sake.
Star K; Edwards IR
Drug Saf; 2014 Feb; 37(2):91-8. PubMed ID: 24446277
[TBL] [Abstract][Full Text] [Related]
2. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
3. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
4. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
Herrera Comoglio R
Br J Clin Pharmacol; 2020 Apr; 86(4):779-790. PubMed ID: 31770452
[TBL] [Abstract][Full Text] [Related]
5. Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention.
Goedecke T; Ord K; Newbould V; Brosch S; Arlett P
Drug Saf; 2016 Jun; 39(6):491-500. PubMed ID: 26940903
[TBL] [Abstract][Full Text] [Related]
6. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
Kunac DL; Tatley MV
Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
[TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance and communicating safety information.
Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564
[TBL] [Abstract][Full Text] [Related]
8. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
Gotta V; van den Anker J; Pfister M
Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
[TBL] [Abstract][Full Text] [Related]
9. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
Santoro A; Genov G; Spooner A; Raine J; Arlett P
Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action.
Radecka A; Loughlin L; Foy M; de Ferraz Guimaraes MV; Sarinic VM; Di Giusti MD; Lesicar M; Straus S; Montero D; Pallos J; Ivanovic J; Raine J
Drug Saf; 2018 Dec; 41(12):1285-1302. PubMed ID: 30128638
[TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
Härmark L; Raine J; Leufkens H; Edwards IR; Moretti U; Sarinic VM; Kant A
Drug Saf; 2016 Oct; 39(10):883-90. PubMed ID: 27379887
[TBL] [Abstract][Full Text] [Related]
13. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance of Biologics in a Multisource Environment.
Sagi S; Cohen HP; Woollett GR
J Manag Care Spec Pharm; 2017 Dec; 23(12):1249-1254. PubMed ID: 29172979
[TBL] [Abstract][Full Text] [Related]
15. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
16. Monitoring medicines use: the role of the clinical pharmacologist.
Williams D
Br J Clin Pharmacol; 2012 Oct; 74(4):685-90. PubMed ID: 22554404
[TBL] [Abstract][Full Text] [Related]
17. [Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association].
Köberle U; Stammschulte T; Gundert-Remy U; Pitzer M; Bräutigam K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1066-1074. PubMed ID: 30022236
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance in China: development and challenges.
Zhao Y; Wang T; Li G; Sun S
Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
[TBL] [Abstract][Full Text] [Related]
19. c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children - A c4c expert group white paper.
Aurich B; Apele-Freimane D; Banaschewski T; Chouchana L; Day S; Kaguelidou F; Kelly LE; Kindblom JM; Neubert A; Wong ICK
Br J Clin Pharmacol; 2022 Dec; 88(12):4997-5016. PubMed ID: 34699077
[TBL] [Abstract][Full Text] [Related]
20. Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media.
Ghosh R; Lewis D
Expert Opin Drug Saf; 2015; 14(12):1845-53. PubMed ID: 26436834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
